Mesoblast Limited (MESO)
(Delayed Data from NSDQ)
$6.24 USD
+0.09 (1.46%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $6.29 +0.05 (0.80%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth F Momentum F VGM
Cash flow Statements
Fiscal Year End for Mesoblast Limited falls in the month of June.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -81.89 | -91.35 | -98.81 | -77.94 | -89.80 |
Depreciation/Amortization & Depletion | 4.11 | 4.38 | 4.26 | 3.67 | 2.14 |
Net Change from Assets/Liabilities | -2.47 | 4.87 | -8.42 | 13.29 | 20.44 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 16.99 | 16.32 | -3.72 | 4.62 | 9.43 |
Net Cash From Operating Activities | -63.27 | -65.78 | -106.68 | -56.37 | -57.79 |
Property & Equipment | -0.26 | -0.16 | -1.65 | -2.10 | -0.28 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.07 | -0.08 | 0.00 | -1.18 | -0.72 |
Net Cash from Investing Activities | -0.19 | -0.23 | -1.65 | -3.27 | -1.00 |
Uses of Funds
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 88.64 | 8.29 | 119.24 | 144.95 | 30.26 |
Issuance (Repayment) of Debt | 0.00 | -3.54 | 0.00 | 0.00 | 43.57 |
Increase (Decrease) Short-Term Debt | -2.66 | -2.79 | -2.93 | -1.63 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -11.48 | -11.83 | -1.84 | -6.28 | -2.22 |
Net Cash from Financing Activities | 74.50 | -9.87 | 114.47 | 137.04 | 71.61 |
Effect of Exchange Rate Changes | -0.17 | -0.55 | 1.42 | 1.50 | -0.16 |
Net Change In Cash & Equivalents | 10.87 | -76.43 | 7.55 | 78.90 | 12.66 |
Cash at Beginning of Period | 60.45 | 136.88 | 129.33 | 50.43 | 37.76 |
Cash at End of Period | 71.32 | 60.45 | 136.88 | 129.33 | 50.43 |
Diluted Net EPS | -1.11 | -1.41 | -1.63 | -1.47 | -1.82 |
Fiscal Year End for Mesoblast Limited falls in the month of June.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | NA | NA | -81.89 | -59.97 |
Depreciation/Amortization & Depletion | NA | NA | NA | 4.11 | 3.18 |
Net Change from Assets/Liabilities | NA | -34.00 | NA | -2.47 | -2.46 |
Net Cash from Discontinued Operations | NA | NA | NA | 0.00 | 0.00 |
Other Operating Activities | NA | 7.42 | NA | 16.99 | 12.26 |
Net Cash From Operating Activities | NA | -26.57 | NA | -63.27 | -46.99 |
Property & Equipment | NA | -0.19 | NA | -0.26 | -0.23 |
Acquisition/ Disposition of Subsidiaries | NA | NA | NA | 0.00 | 0.00 |
Investments | NA | NA | NA | 0.00 | 0.00 |
Other Investing Activities | NA | 0.11 | NA | 0.07 | 0.02 |
Net Cash from Investing Activities | NA | -0.09 | NA | -0.19 | -0.21 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 39.71 | NA | 88.64 | 45.07 |
Issuance (Repayment) of Debt | NA | NA | NA | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | -2.15 | NA | -2.66 | -1.79 |
Payment of Dividends & Other Distributions | NA | NA | NA | 0.00 | 0.00 |
Other Financing Activities | NA | -5.96 | NA | -11.48 | -7.53 |
Net Cash from Financing Activities | NA | 31.60 | NA | 74.50 | 35.75 |
Effect of Exchange Rate Changes | NA | 1.30 | NA | -0.17 | -0.19 |
Net Change In Cash & Equivalents | NA | 6.24 | NA | 10.87 | -11.65 |
Cash at Beginning of Period | NA | 71.32 | NA | 60.45 | 60.45 |
Cash at End of Period | NA | 77.55 | NA | 71.32 | 48.80 |
Diluted Net EPS | NA | NA | NA | -0.28 | -0.25 |